Archives

img-01

2017 Update on the Diabetes Market in Asia

This article was originally published on MedTech Intelligence. Introduction According to the World Health Organization (WHO), there are around 430 million diabetics worldwide, a number that will grow to 650 million by 2040. 60% of diabetics are Asian, and diabetes is currently... Read More

img-01

Sports Medicine in Asia 2017

This article was originally published on MedTech Intelligence. Introduction Sports medicine is the treatment of injuries or health problems related to exercise, sports, or any other health activity. Asia accounts for approximately 15 percent of the global sports medicine market, which was... Read More

img-01

Orphan Drugs in Asia Report 2017

Following the example of the U.S. FDA's Orphan Drug Act established in 1983, some Asian countries have developed orphan drug legislation, such as Singapore's Orphan Drug Exemption to the Medicines Act and Japan's Orphan Drug Amendment to the Pharmaceutical Affairs Law. While... Read More

img-01

Smaller Economies in Asia to Boost MedTech Market

This article was also published on Medtech Intelligence.  Asia is the largest and most populous continent in the world. With a population greater than 4.4 billion (or about two-thirds of the world’s population), there are tremendous medtech opportunities in the region. Nowadays,... Read More

img-01

Diabetes In Asia

Studies have shown that Asians are at a higher risk of developing type II diabetes than Europeans. As Asia is continuing to develop, lifestyle diseases such as diabetes, hypertension, and high cholesterol are on the rise. About 70% of diabetes patients live... Read More

img-01

Asia Aging Quickly, Many Medtech Opportunities

This article was also published on MedTech Intelligence. Asia’s population is aging quickly. The demographics are changing rapidly with declining birth rates and increasing life expectancies, resulting in shifting healthcare trends. The WHO says “ageing well” must be a global priority, because the... Read More